This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Masaaki Mori: Innovator in Colonic Delivery Systems
Introduction
Masaaki Mori is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of pharmaceutical preparations, particularly in the development of innovative delivery systems for medications.
Latest Patents
Masaaki Mori holds a patent for a solid preparation containing chitosan powder and the process for producing the same. This invention focuses on a colonic delivery solid preparation that can control the dissolution of a medicament in the large intestine. The preparation is designed to release the medicament specifically in the large intestine, achieved by coating a medicament-containing solid material with a water-insoluble polymer that has chitosan powder dispersed within it, followed by an enteric polymer. Additionally, the solid preparation can partially release a medicament in the stomach and disintegrate at an accelerated rate in the large intestine, ensuring effective delivery of the medication.
Career Highlights
Masaaki Mori is associated with Dainippon Sumitomo Pharma Co., Ltd., where he has been instrumental in advancing pharmaceutical technologies. His work has focused on enhancing the efficacy of drug delivery systems, particularly for medications intended for colonic administration.
Collaborations
Masaaki has collaborated with notable colleagues such as Norihito Shimono and Yutaka Higashi. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.
Conclusion
Masaaki Mori's contributions to the field of pharmaceutical preparations highlight his role as an innovator in drug delivery systems. His patent for a solid preparation containing chitosan powder exemplifies his commitment to improving medication efficacy and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile